Concepedia
Statistics
Publications
15
Citations
835
H-Index
13
Active since
2005
Affiliations
Dana-Farber Cancer Institute(Current)
Boston Children's Hospital
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Harvard University
Dana-Farber/Harvard Cancer Center
Christine Chordas is an author at Dana-Farber Cancer Institute specializing in medicine, pediatric oncology, and oncology.
Publications per year
2005–2021
A Feasibility Trial of Antiangiogenic (Metronomic) Chemotherapy in Pediatric Patients With Recurrent or Progressive Cancer
Mark W. Kieran, Christopher Turner, Joshua B. Rubin et al. · Journal of Pediatric Hematology/Oncology · 2005 · 202 citations
Medicine, Oncology, Pharmacology +17
A phase II trial of a multi‐agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
Nathan Robison, Federico Campigotto, Susan Chi et al. · Pediatric Blood & Cancer · 2013 · 152 citations · Full text
Medicine, Oncology, Pharmacology +15
Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience
Chantel Cacciotti, Jungwhan John Choi, Sanda Alexandrescu et al. · Journal of Neuro-Oncology · 2020 · 76 citations
Medicine, Oncology, Pediatrics +17
Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma
Neevika Manoharan, Jungwhan John Choi, Christine Chordas et al. · Journal of Neuro-Oncology · 2020 · 75 citations
Medicine, Oncology, Pediatrics +12
Medical, psychological, cognitive and educational late‐effects in pediatric low‐grade glioma survivors treated with surgery only
Christopher D. Turner, Christine Chordas, Cori Liptak et al. · Pediatric Blood & Cancer · 2009 · 73 citations
1–5 of 15